We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$310M
2
SPG icon
Simon Property Group
SPG
+$93.4M
3
FR icon
First Industrial Realty Trust
FR
+$90.7M
4
PSA icon
Public Storage
PSA
+$88.6M
5
DOC icon
Healthpeak Properties
DOC
+$58M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
1076
Legend Biotech
LEGN
$3.65B
$13K ﹤0.01%
261
+62
+31% +$3K
RARE icon
1077
Ultragenyx Pharmaceutical
RARE
$2.46B
$13K ﹤0.01%
282
+21
+8% +$826
ABCL icon
1078
AbCellera Biologics
ABCL
$1.65B
$12K ﹤0.01%
1,151
+91
+9% +$1.05K
OUT icon
1079
Outfront Media
OUT
$5.75B
$12K ﹤0.01%
734
-53
-7% -$895
PRTA icon
1080
Prothena Corp
PRTA
$449M
$12K ﹤0.01%
195
+41
+27% +$2.4K
XYZ
1081
PUT
Block Inc
XYZ
$48.9B
$12K ﹤0.01%
+500
New +$30.9K
BEAM icon
1082
Beam Therapeutics
BEAM
$2.68B
$11K ﹤0.01%
283
+21
+8% +$941
BPMC
1083
DELISTED
Blueprint Medicines
BPMC
$11K ﹤0.01%
241
+19
+9% +$911
GH icon
1084
Guardant Health
GH
$19.1B
$11K ﹤0.01%
412
+32
+8% +$1.46K
INSM icon
1085
Insmed
INSM
$22.3B
$11K ﹤0.01%
545
+100
+22% +$1.93K
PTCT icon
1086
PTC Therapeutics
PTCT
$6.17B
$11K ﹤0.01%
289
+23
+9% +$956
MRTX
1087
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11K ﹤0.01%
232
+25
+12% +$1.62K
ACAD icon
1088
Acadia Pharmaceuticals
ACAD
$4.51B
$10K ﹤0.01%
651
+182
+39% +$2.85K
AKRO
1089
DELISTED
Akero Therapeutics
AKRO
$10K ﹤0.01%
188
+69
+58% +$2.96K
AMLX icon
1090
Amylyx Pharmaceuticals
AMLX
$2.19B
$10K ﹤0.01%
+266
New +$9.44K
XENE icon
1091
Xenon Pharmaceuticals
XENE
$6.1B
$10K ﹤0.01%
252
+54
+27% +$1.97K
ISEE
1092
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10K ﹤0.01%
485
+51
+12% +$1.09K
IMVT icon
1093
Immunovant
IMVT
$7.93B
$9K ﹤0.01%
520
+126
+32% +$1.59K
RVMD icon
1094
Revolution Medicines
RVMD
$38.4B
$9K ﹤0.01%
357
+80
+29% +$1.7K
SAGE
1095
DELISTED
Sage Therapeutics
SAGE
$9K ﹤0.01%
239
+19
+9% +$726
ZLAB icon
1096
Zai Lab
ZLAB
$2.07B
$9K ﹤0.01%
278
+23
+9% +$726
BCRX icon
1097
BioCryst Pharmaceuticals
BCRX
$2.42B
$8K ﹤0.01%
692
– –
BFAM icon
1098
Bright Horizons
BFAM
$4.35B
$8K ﹤0.01%
+125
New +$8.18K
IBRX icon
1099
ImmunityBio
IBRX
$7.15B
$8K ﹤0.01%
1,610
+127
+9% +$697
KRYS icon
1100
Krystal Biotech
KRYS
$10.7B
$8K ﹤0.01%
96
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.